Aphasia study: Adaptive Spacing Condition
Official title Adaptive Trial Scheduling in Naming Treatment for Aphasia
ClinicalTrials.gov ID: NCT05653466
What this study is testing
- What it's testing
- This study wants to see if changing the timing of practice helps people keep their word-finding skills longer and use them in daily life.
- Who it's for
- People who have trouble finding words after a stroke or other brain injury.
- What's involved
- Participants will take part in naming exercises where the time between practice sessions changes based on their progress.
- Time commitment
- The source text does not specify the total duration or number of visits required.
- Phase 2: a mid-size study of how well it works
Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Existing diagnosis of chronic (\>6 months) aphasia subsequent to left hemisphere stroke.
- Impaired performance on 2/8 sections of the Comprehensive Aphasia Test.
- Must have access to a high-speed internet connection and be able to participate in telehealth.
You likely can't join if
- History of other acquired or progressive neurological disease.
- Significant language comprehension impairments
- Unmanaged drug / alcohol dependence.
- Severe diagnosed mood or behavioral disorders that require specialize mental health interventions.
The study team makes the final eligibility decision.
Where it is enrolling
- Pittsburgh, Pennsylvania, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part, but confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
This study is enrolling now at Pittsburgh, Pennsylvania, United States. Enter your location above to see the nearest enrolling site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool that is independent of the study sponsor. Details come from ClinicalTrials.gov. The study team decides eligibility, and your own doctor gives medical advice.